CBZ-OsuCAS# 13139-17-8 |
- CI994 (Tacedinaline)
Catalog No.:BCC2159
CAS No.:112522-64-2
- Tubastatin A HCl
Catalog No.:BCC3877
CAS No.:1310693-92-5
- M344
Catalog No.:BCC2162
CAS No.:251456-60-7
- AR-42 (OSU-HDAC42)
Catalog No.:BCC2161
CAS No.:935881-37-1
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 13139-17-8 | SDF | Download SDF |
PubChem ID | 83172 | Appearance | Powder |
Formula | C12H11NO5 | M.Wt | 249.24 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in water or 1% acetic acid | ||
Chemical Name | benzyl (2,5-dioxopyrrolidin-1-yl) carbonate | ||
SMILES | C1CC(=O)N(C1=O)OC(=O)OCC2=CC=CC=C2 | ||
Standard InChIKey | MJSHDCCLFGOEIK-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C12H11NO5/c14-10-6-7-11(15)13(10)18-12(16)17-8-9-4-2-1-3-5-9/h1-5H,6-8H2 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
CBZ-Osu Dilution Calculator
CBZ-Osu Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.0122 mL | 20.061 mL | 40.122 mL | 80.2439 mL | 100.3049 mL |
5 mM | 0.8024 mL | 4.0122 mL | 8.0244 mL | 16.0488 mL | 20.061 mL |
10 mM | 0.4012 mL | 2.0061 mL | 4.0122 mL | 8.0244 mL | 10.0305 mL |
50 mM | 0.0802 mL | 0.4012 mL | 0.8024 mL | 1.6049 mL | 2.0061 mL |
100 mM | 0.0401 mL | 0.2006 mL | 0.4012 mL | 0.8024 mL | 1.003 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
CBZ-Osu
- Boc-Ile-OH.1/2H2O
Catalog No.:BCC3406
CAS No.:13139-16-7
- Boc-Leu-OH.H2O
Catalog No.:BCC3408
CAS No.:13139-15-6
- Boc-Trp-OH
Catalog No.:BCC3455
CAS No.:13139-14-5
- Teijin compound 1
Catalog No.:BCC6057
CAS No.:1313730-14-1
- Periplocin
Catalog No.:BCN2655
CAS No.:13137-64-9
- erythro-Guaiacylglycerol beta-threo-syringylglycerol ether
Catalog No.:BCN7333
CAS No.:1313434-74-0
- NVP-CGM097
Catalog No.:BCC5395
CAS No.:1313363-54-0
- Nystose
Catalog No.:BCN5397
CAS No.:13133-07-8
- threo Ifenprodil hemitartrate
Catalog No.:BCC7508
CAS No.:1312991-83-5
- Ro 8-4304 hydrochloride
Catalog No.:BCC7655
CAS No.:1312991-77-7
- Ro 25-6981 Maleate
Catalog No.:BCC4159
CAS No.:1312991-76-6
- Scutebarbatine Z
Catalog No.:BCN6991
CAS No.:1312716-28-1
- Hemopressin (human, mouse)
Catalog No.:BCC6065
CAS No.:1314035-51-2
- TC-N 22A
Catalog No.:BCC6150
CAS No.:1314140-00-5
- UNC669
Catalog No.:BCC3997
CAS No.:1314241-44-5
- Cercosporamide
Catalog No.:BCC2438
CAS No.:131436-22-1
- Amyloid Beta-Peptide (1-40) (human)
Catalog No.:BCC1045
CAS No.:131438-79-4
- TMP269
Catalog No.:BCC3993
CAS No.:1314890-29-3
- HG6-64-1
Catalog No.:BCC5459
CAS No.:1315329-43-1
- B-Raf inhibitor
Catalog No.:BCC1437
CAS No.:1315330-11-0
- NG25
Catalog No.:BCC1799
CAS No.:1315355-93-1
- pep2-EVKI
Catalog No.:BCC5786
CAS No.:1315378-67-6
- pep2-AVKI
Catalog No.:BCC5787
CAS No.:1315378-69-8
- TCS 184
Catalog No.:BCC5899
CAS No.:1315378-71-2
Catalytic asymmetric hydrogenation of 3-substituted benzisoxazoles.[Pubmed:22728365]
Molecules. 2012 Jun 6;17(6):6901-15.
A variety of 3-substituted benzisoxazoles were reduced with hydrogen using the chiral ruthenium catalyst, {RuCl(p-cymene)[(R,R)-(S,S)-PhTRAP]}Cl. The ruthenium-catalyzed hydrogenation proceeded in high yield in the presence of an acylating agent, affording alpha-substituted o-hydroxybenzylamines with up to 57% ee. In the catalytic transformation, the N-O bond of the benzisoxazole substrate is reductively cleaved by the ruthenium complex under the hydrogenation conditions. The C-N double bond of the resulting imine is saturated stereoselectively through the PhTRAP-ruthenium catalysis. The hydrogenation produces chiral primary amines, which may work as catalytic poisons, however, the amino group of the hydrogenation product is rapidly acylated when the reaction is conducted in the presence of an appropriate acylating agent, such as Boc(2)O or CBZ-Osu.